Drug
Ingenol Mebutate 0 015
Ingenol Mebutate 0 015: highest development phase Phase 1, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ingenol mebutate 0.015% NCT02411851 | Phase 1 | Actinic Keratoses |
Latest
No recent events.
Follow Ingenol Mebutate 0 015 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.